<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><!-- InstanceBegin template="/Templates/ContentPage_Standard.dwt" codeOutsideHTMLIsLocked="false" -->

<head>
<!-- InstanceParam name="id" type="text" value="undefined" --><!-- InstanceParam name="class" type="text" value="secondTier" --><!-- InstanceParam name="content" type="boolean" value="true" --><!-- InstanceParam name="optionSpanish" type="boolean" value="false" --><!-- InstanceParam name="optionalFeatures" type="boolean" value="false" --><!-- InstanceParam name="OptionalLocalSearch" type="boolean" value="false" --><!-- InstanceParam name="OptionalLocalA-Z" type="boolean" value="false" --><!-- InstanceParam name="optionalExtra" type="boolean" value="false" --><!-- InstanceParam name="JqueryUI" type="boolean" value="false" --><!-- InstanceParam name="JqueryUiAccordion" type="boolean" value="false" --><!-- InstanceParam name="dojoLibrary" type="boolean" value="false" -->
<meta http-equiv="content-type" content="text/html; charset=utf-8" />
<!-- InstanceBeginEditable name="meta-data" -->
<meta name="Keywords" 		content="HICPAC, infection prevention and control guidelines and recommendation, Updating the Guideline Methodology, Guideline for the Prevention and Control of Norovirus Gastroenteritis Outbreaks in Healthcare Settings, Guideline for the Prevention of Intravascular Catheter-Related Bloodstream Infections, BSI guidelines, Norovirus guidelines, Guideline for Prevention of Catheter-associated Urinary Tract Infections, UTI guidelines, Guideline for Disinfection and Sterilization in Healthcare Facilities, Disinfection and Sterilization Guidelines, Guideline for Isolation Precautions, Guideline for Hand Hygiene in Healthcare Settings, Guidance on Public Reporting of HAIs, Guideline for Preventing Healthcare-Associated Pneumonia, Guideline for the Prevention of Surgical Site Infection, SSI Guidelines, Management of Multidrug-Resistant Organisms In Healthcare Settings, MDRO, Guidance for Control of Infections with Carbapenem-Resistant or Carbapenemase-Producing Enterobacteriaceae in Acute Care Facilities, Guideline for Infection Control in Hospital Personnel,  Recommendations for Using Smallpox Vaccine in a Pre-Event Vaccination Program, Immunization of Health-Care Workers: Recommendations of ACIP and HICPAC, HICPAC current roster, healthcare, health departments, healthcare providers, antimicrobial, antibiotic-resistant, pathogens, Coagulase-negative staphylococci, Staphylococcus aureus, Enterococcus species, Candida species, Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Enterobacter species, Acinetobacter baumannii, Klebsiella oxytoca, multidrug-resistant, Methicillin-resistant Staphylococcus aureus, Vancomycin-resistant Enterococci (VRE) faecium, Carbapenem-resistant P. aeruginosa, Extended-spectrum cephalosporin-resistant K. pneumoniae, Carbapenem-resistant A. baumannii, VISA/VERS, Acinetobacter, Burkholderia cepacia, Clostridium sordellii, CDAD, CDI, Enterobacteriaceae (Carbapenem-resistance),Hepatitis, Klebsiella, MRSA, Mycobacterium abscessus, Norovirus, Staphylococcus aureus, Tuberculosis (TB),Vancomycin-intermediate Staphylococcus aureus, Vancomycin-resistant Staphylococcus aureus, Surgical Site Infection (SSI), Ventilator-associated Pneumonia (VAP), Ambulatory Settings, Ambulatory surgical centers, Dialysis Setting, Long-term care facilities (LTCFs), LTC " />
<meta name="DC.Subject" 	content="" />
<meta name="DC.Language" 	scheme="ISO 639-2" content="eng" />
<!-- InstanceEndEditable -->
<meta name="template.version" content="2.5.2" />
<!-- @package: TemplatePackage 'B' @version: "2.5.2" -->
<!-- InstanceBeginEditable name="title-tag" -->
<title>CDC - Guideline for Prevention of Catheter-associated Urinary Tract Infections, 2009 - HICPAC</title>
<!-- InstanceEndEditable -->
<style type="text/css" media="tv">
empty{color:#000};@import "../../TemplatePackage/css/B/wysiwyg/wysiBaseHome.css"/**/;
</style>
<style type="text/css" media="screen, projection">
@import "../../TemplatePackage/css/B/base-float.css"/**/;
</style>
<script type="text/javascript" src="../../TemplatePackage/js/B/jquery.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/jquery.watermark.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/common.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/startup.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/blocks-ie.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/video.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/navScripts.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/share.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/govdelivery.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/external.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/plugins.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/syndicateThisPage.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/css-include.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/socialMedia.js"></script>

<!-- compliance patch for microsoft browsers -->
<!--[if IE 6]>
<script type="text/javascript" src="/TemplatePackage/js/B/pngfix.js"></script>
<script type="text/javascript" src="/TemplatePackage/js/B/blocks-ie6.js"></script>
<![endif]-->

<!--[if IE 7]>
<link rel="stylesheet" type="text/css" href="/TemplatePackage/css/B/ie7_fixes.css" />
<![endif]-->

<!--[if IE 8]>
<link rel="stylesheet" type="text/css" href="/TemplatePackage/css/B/ie8_fixes.css" />
<![endif]-->

<!--[if lte IE 8]>
<script type="text/javascript" src="/TemplatePackage/js/B/jquery.curvycorners.js"></script>
<![endif]-->
<style type="text/css" media="print">@import "../../TemplatePackage/css/B/print.css";</style>

<link rel="shortcut icon" href="../../TemplatePackage/images/home/favicon.ico" />
<link rel="home" href="../../index.html" title="Home" />

<!-- Begin Survey scripts -->
<script type="text/javascript" src="../../JScript/foresee/foresee-trigger.js"></script>
<script type="text/javascript" src="../../JScript/foresee-variables.js"></script>
<!-- End Survey scripts -->


<!-- Local Topic Styles -->
<!-- InstanceBeginEditable name="local-css" -->
<style type="text/css" media="all">
@import "../local/B/css/local.css"/**/;
</style>
<!--[if IE]>
<script defer language="javascript" type="text/javascript">
		var cdcLeftNav = new CDC.LeftNav("nav-primary");
		cdcLeftNav.render();
</script>
<![endif]-->
<!--[if ! IE]><!-->
<script language="javascript" type="text/javascript">
$().ready(function(){
		
		var cdcLeftNav = new CDC.LeftNav("nav-primary", location.pathname, true, true);
		cdcLeftNav.render();

});
</script>
<!--<![endif]-->

<!-- InstanceEndEditable -->
</head>
<body id="undefined" class="secondTier">

<div id="skipmenu">
	<a href="003_SSI.html#searchBox" class="skippy" title="Skip to search">Skip directly to search</a>
	<a href="003_SSI.html#az" class="skippy" title="Skip to A to Z list">Skip directly to A to Z list</a>
	<a href="003_SSI.html#nav" class="skippy" title="Skip to navigation">Skip directly to navigation</a>
	<a href="003_SSI.html#content-main" class="skippy" title="Skip to content">Skip directly to site content</a>
	<a href="003_SSI.html#content-secondary" class="skippy" title="Skip to page options">Skip directly to page options</a>
</div>
<div id="wrapper">
	<div class="top"></div>
	<div id="wrapper-inner">
		<div id="branding">
			<span id="homeward"><a href="../../index.html" title="Return to the CDC Home Page">CDC Home</a></span>
<div id="branding-logo">
	<div id="branding-logoImage"><img src="../../TemplatePackage/images/cdcHeaderLogo.gif" width="470" height="47" alt="CDC 24/7: Saving Lives. Protecting People.&trade;" border="0" /><a href="../../index.html" title="CDC 24/7: Saving Lives. Protecting People.&trade;"><span>CDC 24/7: Saving Lives. Protecting People.&trade;</span></a></div>
	<div id="searchForm" class="searchResize"><a name="search"></a>
		<form id="searchCDC" method="get" action="https://search.cdc.gov/search">
			<fieldset>
				<div id="cdc-Query">
					<label for="searchBox" class="overlabel search">Search The CDC</label>
					<input id="searchBox" class="searchBox" name="query" maxlength="256" type="text" />
				</div>
				<div id="cdc-Submit">
					<!-- label for="searchButton" class="searchButton">Search Button</label -->
					<input id="searchButton" class="searchButton" src="../../TemplatePackage/images/home/search_button.gif" name="searchButton" alt="Search" type="image" />
					<input name="action" value="search" type="hidden" />
				</div>
				<input type="hidden" name="utf8" value="&#x2713;"/>
				<input type="hidden" name="affiliate" value="cdc-main"/>
			</fieldset>
		</form>
	</div>
</div>
<noscript>
<div class="noscript"> Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page: <a href="../../Other/about_cdcgov.html" title="Browser requirements for CDC.gov">About CDC.gov</a>.</div>
</noscript>
<!--<div id="emergency-alert">
<h1></h1> 
<p></p>
<a href="#"></a>
</div>-->
			<div id="topic-title"><!-- InstanceBeginEditable name="topic-title" -->
			<h2><a href="../index.html">Healthcare Infection Control Practices Advisory Committee (HICPAC)</a></h2>
			<!-- InstanceEndEditable -->
			</div>
		</div>
		
		<div id="content">
			<div id="content-inner">
				
				<!-- ########## LEFT NAVIGATION STARTS HERE ########## -->
				<div id="nav-container"><!-- InstanceBeginEditable name="left-nav-include" -->
				<div id="nav">
  <h3><a href="../index.html">HICPAC</a></h3>
	<ul id="nav-primary">
    <li><a href="../about.html">About HICPAC</a></li>
    <li><a href="../roster.html">Member Roster</a></li>
    <li><a href="../charter.html">Charter</a> </li>
    <li><a href="../eCalendar.html">Event Calendar</a>
      <!--ul>
        <li><a href="/hicpac/agenda.html">Meeting Agenda</a></li>  
      </ul-->
    </li>
    <li><a href="../guidelineMethod/guidelineMethod.html">Methodology Guideline</a>
      <ul>
        <li><a href="../guidelineMethod/001_methods_background.html">Background</a></li>
        <li><a href="../guidelineMethod/002_methods_emergingNeeds.html">Strengthening HICPAC Guidelines to Address Emerging Needs</a></li>
        <li><a href="../guidelineMethod/003_methods_Organiz2AccomplishGoals.html">Organizing to Accomplish Our Goals</a> </li>
        <li><a href="../guidelineMethod/004_methods_guidelineDevelopment.html">Methods in Guideline Development</a></li>
        <li><a href="../guidelineMethod/005_methods_challengesOpportunities.html">Looking to Future Challenges and Opportunities</a></li>
        <li><a href="../guidelineMethod/007_methods_References.html">References</a></li>
        <li><a href="../guidelineMethod/008_methods_tables.html">Tables</a></li>
        <li><a href="../guidelineMethod/011_methods_figures.html">Figures</a></li>
      </ul>
    </li>
	<!--li><a href="/hicpac/projects_in_progress.html">Projects in Progress</a></li-->
	<li><a href="../pubs.html">Publications</a>
			<ul>
			  <li><a href="../BSI/BSI-guidelines-2011.html">2011 Guidelines for the Prevention of Intravascular Catheter-Related Infections</a>
		        <ul>
		          <li><a href="../BSI/toc-BSI-guidelines-2011.html">Table of Contents</a></li>
		          <li><a href="../BSI/01-BSI-guidelines-2011.html">Notice to Readers</a> </li>
		          <li><a href="../BSI/02-bsi-summary-of-recommendations-2011.html">Summary Of Recommendations</a> </li>
		          <li><a href="../BSI/03-bsi-summary-of-recommendations-2011.html">Patient Cleansing 
		            </a></li>
		          <li><a href="../BSI/04-bsi-background-info-2011.html">Background Information</a></li>
		          <li><a href="../BSI/05-bsi-background-info-2011.html">Maximal Sterile Barrier Precautions 
		            </a></li>
		          <li><a href="../BSI/06-bsi-background-info-2011.html">Antibiotic Lock Prophylaxis, Antimicrobial Catheter Flush and Catheter Lock Prophylaxis 
		            </a></li>
		          <li><a href="../BSI/07-bsi-background-info-2011.htmles-2011.html">Replacement of Administration Sets</a></li>
		          <li><a href="../BSI/bsi-table-1-2011.html">Table 1. Catheters used for venous and arterial access</a></li>
		          <li><a href="../BSI/13-references-BSI-guidelines-2011.html">References</a></li>
		          <li><a href="../BSI/11-appendix-B-BSI-guidelines-2011.html">Appendix B. Disclosure of financial interests or relationships</a></li>
		          <li><a href="../BSI/12-appendix-C-BSI-guidelines-2011.html">Appendix C. Summary of Recommendations</a></li>
	            </ul>
			  </li>
		      <li><a href="../norovirus/002_norovirus-toc.html">2011 Norovirus Guidelines
		        </a>
		        <ul>
		          <li><a href="../norovirus/003_norovirus-abbreviations.html">Abbreviations</a></li>
					   
					   <li><a href="../norovirus/001_norovirus.html">Acknowledgement</a></li>
					   <li><a href="../norovirus/004_norovirus-exec-summary.html">Executive Summary</a></li>
					   <li><a href="../norovirus/005_norovirus-summaryOrecs.html">Summary of Recommendations</a></li>
					   <li><a href="../norovirus/006_norovirus-implement-audit.html">Implementation and Audit</a> </li>
					   <li> <a href="../norovirus/007_norovirus-recs-further-research.html">Recommendations for Further Research					     </a></li>
					   <li><a href="../norovirus/008_norovirus-background.html">Background					     </a></li>
					   <li><a href="../norovirus/009_norovirus-scope.html">Scope and Purpose</a> </li>
					   <li><a href="../norovirus/010_norovirus-methods.html">Methods</a> </li>
					   <li><a href="../norovirus/011_norovirus-evidence-review.html">Evidence Review Question 1</a>				       </li>
                       <li><a href="../norovirus/012_norovirus-evidence-q2.html">Question 2</a></li>
                       <li><a href="../norovirus/013_norovirus-evidence-q3.html">Question 3</a></li>
                  <li><a href="../norovirus/norovirus-appendix-1.html">Appendix 1</a></li>
                       <li><a href="../norovirus/norovirus-appendix-1b.html">Appendix 1B</a> </li>
                       <li><a href="../norovirus/tables/evidence-Table1.html">Evidence, Grade &amp; Study Quality Assessment Tables</a></li>
                  <li><a href="../norovirus/norovirus-appendix-3.html">Appendix 3</a></li>
                       <li><a href="../norovirus/norovirus-appendix-4.html">Appendix 4</a></li>
                       <li><a href="../norovirus/norovirus-references.html">References</a></li>
		        </ul>
		      </li>
	          <li><a href="../Disinfection_Sterilization/acknowledg.html">2008 Disinfection &amp; Sterilization Guideline</a>               
	            <ul>
	              <li><a href="../Disinfection_Sterilization/toc.html">Table of Contents</a></li>
	              <li><a href="../Disinfection_Sterilization/1_sumIntroMethTerms.html">Executive Summary</a> </li>
	              <li><a href="../Disinfection_Sterilization/2_approach.html">Approach to Disinfection and Sterilization</a> 
	                  <ul>
	                    <li><a href="../Disinfection_Sterilization/3_0disinfectEquipment.html">Disinfection of Healthcare Equipment</a></li>
                        <li><a href="../Disinfection_Sterilization/3_1deLaparoArthro.html">Laparoscopes and Arthroscopes</a> </li>
                        <li><a href="../Disinfection_Sterilization/3_2contaminatedDevices.html">Disinfection of HBV, HCV, HIV or TB-Contaminated Devices</a></li>
                        <li><a href="../Disinfection_Sterilization/3_3inactivBioAgents.html">Inactivation of Bioterrorist Agents</a></li>
                        <li><a href="../Disinfection_Sterilization/3_4surfaceDisinfection.html">Surface Disinfection</a></li>
                    </ul>
	              </li>
                  <li><a href="../Disinfection_Sterilization/4_0efficacyDS.html">Factors Affecting The Efficacy Of Disinfection And Sterilization</a></li>
                  <li><a href="../Disinfection_Sterilization/5_0cleaning.html">Cleaning</a></li>
                  <li><a href="../Disinfection_Sterilization/6_0disinfection.html">Disinfection</a>
                    <ul>
                      <li><a href="../Disinfection_Sterilization/7_0formaldehyde.html">Formaldehyde</a></li>
                      <li><a href="../Disinfection_Sterilization/8_0Iodophors.html">Iodophors</a></li>
                      <li><a href="../Disinfection_Sterilization/9_0PceticAcidHydroPoxide.html">Peracetic Acid and Hydrogen Peroxide</a></li>
                    </ul>
                  </li>
                  <li><a href="../Disinfection_Sterilization/10_0MiscAgents.html">Miscellaneous Inactivating Agents</a></li>
                  <li><a href="../Disinfection_Sterilization/11_0regulatory_Framework.html">Regulatory Framework for Disinfectants and Sterilants</a></li>
                  <li><a href="../Disinfection_Sterilization/13_0Sterilization.html">Sterilization</a>
                      <ul>
	                      
                        <li><a href="../Disinfection_Sterilization/13_02sterilization.html">Low-Temperature Sterilization Technologies</a></li>
		                          
                        <li><a href="../Disinfection_Sterilization/13_06PeraceticAcidSterilization.html">Peracetic Acid Sterilization</a></li>
		                         
                        <li><a href="../Disinfection_Sterilization/13_10otherSterilizationMethods.html">Other Sterilization Methods</a></li>
                        <li><a href="../Disinfection_Sterilization/13_11sterilizingPractices.html">Sterilizing Practices</a></li>
                    </ul>
                  </li>
                  <li><a href="../Disinfection_Sterilization/14_00ReuseMedicalDevices.html">Reuse of Single-Use Medical Devices</a></li>
                  <li><a href="../Disinfection_Sterilization/17_00Recommendations.html">Recommendations for Disinfection and Sterilization in Health-Care Facilities</a></li>
                  <li><a href="../Disinfection_Sterilization/18_00PerformanceIndicators.html">Performance Indicators</a></li>
                  <li><a href="../Disinfection_Sterilization/19_00glossary.html">Glossary</a></li>
                  <li><a href="../Disinfection_Sterilization/table_1.html">Tables &amp; Figure</a>
                    <ul>
                      <li><a href="../Disinfection_Sterilization/table_2.html">Table 2, 3</a></li>
                      <li><a href="../Disinfection_Sterilization/fig_1.html">Figure 1</a></li>
                      <li><a href="../Disinfection_Sterilization/table_4.html">Table 4</a></li>
                      <li><a href="../Disinfection_Sterilization/table_5.html">Table 5</a></li>
                      <li><a href="../Disinfection_Sterilization/table_6.html">Table 6</a></li>
                      <li><a href="../Disinfection_Sterilization/table_7.html">Table 7, 8, 9</a></li>
                      <li><a href="../Disinfection_Sterilization/table_10.html">Table 10, 11, 12</a></li>
                    </ul>
                  </li>
                  <li><a href="../Disinfection_Sterilization/20_00reference.html">References</a></li>
                </ul>
              </li>
	          <li><a href="../2007IP/2007isolationPrecautions.html">Guideline for Isolation Precautions 2007</a>
				  <ul>
                        <li><a href="../2007IP/2007ip_ExecSummary.html">Executive Summary</a></li>
                        <li> <a href="../2007IP/2007ip_part1.html">Part I: Review of Scientific Data Regarding Transmission of Infectious Agents in Healthcare Settings</a></li>
                        <li><a href="../2007IP/2007ip_part2.html">Part II: Fundamental elements needed to prevent transmission of infectious agents in healthcare settings</a></li>
                        <li><a href="../2007IP/2007ip_part3.html">Part III: Precautions to Prevent Transmission of Infectious Agents</a></li>
                        <li><a href="../2007IP/2007ip_part4.html">Part IV: Recommendations</a></li>
                        <li><a href="../2007IP/2007ip_appendA.html">Appendix A</a></li>
                        <li><a href="../2007IP/2007ip_tables.html">Tables 1 - 5</a>
                          <ul>
                            <li><a href="../2007IP/2007ip_table2.html">Table 2</a></li>
                            <li><a href="../2007IP/2007ip_table3.html">Table 3</a></li>
                            <li><a href="../2007IP/2007ip_table4.html">Table 4</a></li>
                            <li><a href="../2007IP/2007ip_table5.html">Table 5</a></li>
                          </ul>
                        </li>
                        <li><a href="../2007IP/2007ip_fig.html">Figure. Example of Safe Donning and Removal of PPE</a></li>
                        <li><a href="../2007IP/2007ip_glossary.html">Glossary</a></li>
                        <li><a href="../2007IP/2007ip_reference.html">References</a></li>
                </ul>
			  </li>
			    
	            <li><a href="../cauti/001_cauti.html">2009 CAUTI Guideline</a>
	              <ul>
	                <li><a href="../cauti/002_cauti_toc.html">Table of Contents</a>
	                  <!--<ul><li><a href="/hicpac/Disinfection_Sterilization/1_sumIntroMethTerms-levi.html">test</a></li></ul>-->
                    </li>
                      <li><a href="../cauti/02_cauti2009_abbrev.html">Abbreviations</a></li>
                      <li><a href="../cauti/003_cauti2009_execSum.html">I. Executive Summary</a></li>
                      <li><a href="../cauti/002_cauti_sumORecom.html">II. Summary of Recommendations</a></li>
                      <li><a href="../cauti/003_ImplementAudit.html">III. Implementation and Audit</a></li>
                      <li><a href="../cauti/004_furtherResearch.html">IV. Recommendations for Further Research</a></li>
                      <li><a href="../cauti/005_background.html">V. Background</a></li>
                      <li><a href="../cauti/006_scopePurpose.html">VI. Scope and Purpose</a></li>
                      <li><a href="../cauti/007_methods.html">VII. Methods</a></li>
                      <li><a href="../cauti/008_evidenceReview.html">VIII. Evidence Review</a></li>
                      <li><a href="../cauti/009_cauti2009_References.html">References</a></li>
                      <li><a href="../cauti/010_cauti2009_figs.html">Figures</a></li>
		          </ul>
              </li>
              
              <li><a href="../CAUTI_fastFacts.html">CAUTI Guideline Fast Facts</a></li>
              <li><a href="../uti_saint_video.html">Podcast: Dr. Sanjay Saint discusses CAUTIs</a></li>
              <li><a href="../mdro/mdro_0.html">Management of MDRO's in Healthcare Settings</a>
	          <ul>
	            <li><a href="../mdro/mdro_toc.html">Table of Contents</a></li>
	            <li><a href="../mdro/mdro_1.html">Introduction</a></li>
	            <li><a href="../mdro/mdro_2.html">Background</a></li>
	            <li><a href="../mdro/mdro_3.html">Epidemiology of MDROs</a></li>
	            <li><a href="../mdro/mdro_4.html">MDRO Prevention and Control</a></li>
	            <li><a href="../mdro/mdro_4_1.html">Discussion</a></li>
	            <li><a href="../mdro/mdro_5.html">Prevention of transmission of Multidrug Resistant Organisms </a></li>
	            <li><a href="../mdro/mdro_table1.html">Tables 1-2</a></li>
	            <li><a href="../mdro/mdro_table3.html">Table 3</a> </li>
	            <li><a href="../mdro/mdro_glossary.html">Glossary - Multidrug-Resistant Organisms</a></li>
	            <li><a href="../mdro/mdro_reference.html">References</a></li>
              </ul>
	        </li>
	        <li><a href="../pubReportGuide/publicReportingHAI.html">Guidance on Public Reporting of HAIs 2003</a>
			      <ul>
			        <li><a href="../pubReportGuide/prg_tbl1.html">Table 1</a></li>
		            <li><a href="../pubReportGuide/prg_tbl2.html">Table 2</a></li>
                    <li><a href="../pubReportGuide/prHAI_reference.html">Reference</a></li>
	              </ul>
		      </li>
            <li><a href="001_SSI.html">Guideline for Prevention of Surgical Site Infection, 1999 </a>
              <ul>
                <li><a href="toc_SSI.html"> Table of contents</a></li>
                
                <li><a href="002_SSI.html">Surgical Site Infection (SSI): An Overview</a></li>
                <li><a href="003_SSI.html">Microbiology</a></li>
                <li><a href="004_SSI.html"> Operative characteristics: Preoperative issues                                 </a></li>
                <li><a href="005_SSI.html">Operative characteristics: Intraoperative issues 
                                 </a></li>
                <li><a href="006_SSI.html">SSI Surveillance </a></li>
                <li><a href="007_SSI.html">Recommendations for Prevention of SSI</a></li>
                <li><a href="ref-SSI.html">References </a></li>
                <li><a href="figure-SSI.html">Figure</a></li>
                <li><a href="table1-SSI.html">Table 1</a></li>
                <li><a href="table2-SSI.html">Table 2</a></li>
                <li><a href="table3-SSI.html">Table 3</a></li>
                <li><a href="table4-SSI.html">Table 4</a></li>
                <li><a href="table5-SSI.html">Table 5</a></li>
                <li><a href="table6-SSI.html">Table 6</a></li>
                <li><a href="table7-8-9-10-SSI.html">Table 7-8-9-10</a></li>
              </ul>
            </li>
            <li><a href="../Pubs/Antibiotic-Stewardship-Statement.html">Antibiotic Stewardship Statement for Antibiotic Guidelines, 2016</a></li>
      </ul>
	  </li>
       
	<li><a href="../presentations.html">Proceedings &amp; Presentations</a>
	  <!--ul>
	    <li><a href="/hicpac/transcript-07-23.html">July 09 - Interim Guidance for Care of Patients with Confirmed /Suspected 2009 H1N1</a></li>
        <li><a href="/hicpac/h1n12009.html">Summary of Recommendations for Care of Patients with Confirmed /Suspected 2009 H1N1</a></li>
	  </ul-->
	</li>
   
    <!--li><a href="/hicpac/registration.html">HICPAC Online Registration</a></li-->
    <li><a href="../contact.html">Contact HICPAC</a></li>
  </ul>
</div>
<div class="bottom"></div>

				
				<!-- InstanceEndEditable -->
				</div>
				
				<!-- ########## BREADCRUMBS START HERE ########## -->
				<!-- InstanceBeginEditable name="breadcrumbs" -->
			<div id="breadBox">
	<ul id="breadcrumbs">
		<li style="display:none;"></li>
	</ul>
</div>
			<!-- InstanceEndEditable -->
				
				<div id="content-main">
					<div class="main-inner">
						
						<!-- InstanceBeginEditable name="content-main" -->
					 <h1>Guideline for Prevention of Surgical Site Infection, 1999 </h1>
					
                      <div class="module">
                     <p>Download the complete PDF version <a href="https://www.cdc.gov/hicpac/pdf/guidelines/SSI_1999.pdf" >Guideline for Prevention of Surgical Site Infection, 1999 [PDF - 217 KB]</a>.                      </p>
                     </div>
                     
                     <div id="onthispage">
<div class="rounders grey bulleted-links">
<div class="inner">
<div class="t"></div>

<h4>On this Page</h4>
<div class="subc">
<ul>
<li type="A"><a href="003_SSI.html">C. Microbiology</a> </li>
                           <li type="A"> <a href="003_SSI.html#ID">D. Pathogenesis</a> </li>
                           <li type="A"><a href="003_SSI.html#IE">E. Risk and Prevention 
                             </a>
                             <ul>
                               <li><a href="003_SSI.html#IE1">1. Patient characteristics
                               </a>
                                 <ul>
                                   <li><a href="003_SSI.html#IE1a">a. Diabetes</a> </li>
                                   <li><a href="003_SSI.html#IE1b">b. Nicotine use </a></li>
                                   <li><a href="003_SSI.html#IE1c">c. Steroid use                                      </a></li>
                                   <li><a href="003_SSI.html#IE1d">d. Malnutrition</a></li>
                                   <li><a href="003_SSI.html#IE1e">e. Prolonged preoperative hospital stay                                      </a></li>
                                   <li><a href="003_SSI.html#IE1f">f. Preoperative nares colonization with Staphylococcus aureus                                    </a></li>
                                   <li><a href="003_SSI.html#IE1g">g. Perioperative transfusion </a></li>
                                 </ul>
                               </li>
                             </ul>
                           </li>
                    </ul>
</div>
</div>

<div class="b">
<div></div>
</div>
</div>
</div>

                     
                     
                     <h2 id="IC">C. Microbiology</h2>
                     <p>According to data from the NNIS system, the distribution
of pathogens isolated from SSIs has not changed
markedly during the last decade (<a href="table3-SSI.html">Table 3</a>).[<a href="ref-SSI.html#26">26,27</a>]
<em><a href="../../HAI/organisms/staph.html">Staphylococcus aureus</a></em>, coagulase-negative <em>staphylococci,
Enterococcus spp</em>., and <em>Escherichia coli </em>remain the most frequently
isolated pathogens. An increasing proportion of
SSIs are caused by antimicrobial-resistant pathogens, such
as <a href="../../mrsa/index.html">methicillin-resistant <em>S. aureus</em> (MRSA)</a>,[<a href="ref-SSI.html#28">28,29</a>] or by
<em>Candida albicans</em>.[<a href="ref-SSI.html#30">30</a>] From 1991 to 1995, the incidence of
fungal SSIs among patients at NNIS hospitals increased
from 0.1 to 0.3 per 1,000 discharges.[<a href="ref-SSI.html#30">30</a>] The increased proportion
of SSIs caused by resistant pathogens and Candida
spp. may reflect increasing numbers of severely ill and
immunocompromised surgical patients and the impact of
widespread use of broad-spectrum antimicrobial agents.</p>
                     <p>Outbreaks or clusters of SSIs have also been caused
                       by unusual pathogens, such as <em>Rhizopus oryzae, Clostridium
                       perfringens, Rhodococcus bronchialis, Nocardia farcinica,
                       Legionella pneumophila </em>and<em> Legionella dumoffii,</em> and
                       <em>Pseudomonas multivorans</em>. These rare outbreaks have been
                       traced to contaminated adhesive dressings,[<a href="ref-SSI.html#30">31</a>] elastic bandages,
                       [<a href="ref-SSI.html#32">32</a>] colonized surgical personnel,[<a href="ref-SSI.html#33">33,34</a>] tap water,[<a href="ref-SSI.html#35">35</a>] or
                       contaminated disinfectant solutions.[<a href="ref-SSI.html#36">36</a>] When a cluster of
                       SSIs involves an unusual organism, a formal epidemiologic
                       investigation should be conducted.</p>
                       
                       <p class="topOPage"><a href="003_SSI.html#">Top</a></p>
                       
                     <h2 id="ID"> D. Pathogenesis                       </h2>
                       <p>Microbial contamination of the surgical site is a necessary
precursor of SSI. The risk of SSI can be conceptualized
according to the following relationship[<a href="ref-SSI.html#37">37,38</a>]:</p>
                       <p><u>Dose of bacterial contamination &times; virulence</u> = Risk of surgical site infection<br />
Resistance of the host patient</p>
                       
                       <p>Quantitatively, it has been shown that if a surgical
site is contaminated with &gt;105 microorganisms per gram of
tissue, the risk of SSI is markedly increased.39 However, the
dose of contaminating microorganisms required to produce
infection may be much lower when foreign material is
present at the site (i.e., 100 staphylococci per gram of tissue
introduced on silk sutures).[<a href="ref-SSI.html#40">40-42</a>]</p>
                       <p>
Microorganisms may contain or produce toxins and
other substances that increase their ability to invade a host,
produce damage within the host, or survive on or in host
tissue. For example, many gram-negative bacteria produce
endotoxin, which stimulates cytokine production. In turn,
cytokines can trigger the systemic inflammatory response
syndrome that sometimes leads to multiple system organ
failure.[<a href="ref-SSI.html#43">43-45</a>] One of the most common causes of multiple
system organ failure in modern surgical care is intraabdominal
infection.[<a href="ref-SSI.html#46">46,47</a>] Some bacterial surface components,
notably polysaccharide capsules, inhibit phagocytosis,
[<a href="ref-SSI.html#48">48</a>] a critical and early host defense response to microbial
contamination. Certain strains of clostridia and streptococci
produce potent exotoxins that disrupt cell membranes or
alter cellular metabolism. [<a href="ref-SSI.html#49">49</a>] A variety of microorganisms,
including gram-positive bacteria such as coagulasenegative
staphylococci, produce glycocalyx and an associated
component called &quot;slime,&quot;[<a href="ref-SSI.html#50">50-55</a>] which physically shields
bacteria from phagocytes or inhibits the binding or penetration
of antimicrobial agents.[<a href="ref-SSI.html#56">56</a>] Although these and other
virulence factors are well defined, their mechanistic relationship
to SSI development has not been fully determined.</p>
                       <p>
For most SSIs, the source of pathogens is the
endogenous flora of the patient’s skin, mucous membranes,
or hollow viscera.[<a href="ref-SSI.html#57">57</a>] When mucous membranes or skin is
incised, the exposed tissues are at risk for contamination
with endogenous flora.[<a href="ref-SSI.html#58">58</a>] These organisms are usually aerobic
gram-positive cocci (e.g., staphylococci), but may
include fecal flora (e.g., anaerobic bacteria and gramnegative
aerobes) when incisions are made near the perineum
or groin. When a gastrointestinal organ is opened during an operation and is the source of pathogens, gramnegative
bacilli (e.g., <em>E. coli</em>), gram-positive organisms
(e.g., enterococci), and sometimes anaerobes (e.g.,
<em>Bacillus fragilis</em>) are the typical SSI isolates. <a href="table4-SSI.html">Table 4</a> lists
operations and the likely SSI pathogens associated with
them. Seeding of the operative site from a distant focus of
infection can be another source of SSI pathogens,[<a href="ref-SSI.html#59">59-68</a>] particularly
in patients who have a prosthesis or other implant
placed during the operation. Such devices provide a nidus
for attachment of the organism.[<a href="ref-SSI.html#50">50</a>,<a href="ref-SSI.html#69">69-73</a>]</p>
                       <p>Exogenous sources of SSI pathogens include surgical
  personnel (especially members of the surgical
  team), [<a href="ref-SSI.html#74">74-78</a>] the operating room environment (including air),
  and all tools, instruments, and materials brought to the
  sterile field during an operation (refer to &quot;Intraoperative
  Issues&quot; section). Exogenous flora are primarily aerobes,
  especially gram-positive organisms (e.g., staphylococci and
  streptococci). Fungi from endogenous and exogenous
  sources rarely cause SSIs, and their pathogenesis is not
  well understood.[<a href="ref-SSI.html#79">79</a>]</p>
  
                       <p class="topOPage"><a href="003_SSI.html#">Top</a></p>
  
<h2 id="IE">E. Risk and Prevention                       </h2>
                       <p>The term <em>risk factor</em> has a particular meaning in epidemiology
and, in the context of SSI pathophysiology and
prevention, strictly refers to a variable that has a significant,
independent association with the development of SSI after
a specific operation. Risk factors are identified by multivariate
analyses in epidemiologic studies. Unfortunately,
the term risk factor often is used in the surgical literature
in a broad sense to include patient or operation features
which, although associated with SSI development in univariate
analysis, are not necessarily independent predictors.
[<a href="ref-SSI.html#80">80</a>] The literature cited in the sections that follow
includes risk factors identified by both univariate and multivariate
analyses.</p>
                       <p><a href="table5-SSI.html">Table 5</a> lists patient and operation characteristics
                         that may influence the risk of SSI development. These characteristics
                         are useful in two ways: (1) they allow stratification
                         of operations, making surveillance data more comprehensible;
                         and, (2) knowledge of risk factors before certain
                         operations may allow for targeted prevention measures.
                         For example, if it is known that a patient has a remote site
                         infection, the surgical team may reduce SSI risk by scheduling
                         an operation after the infection has resolved.</p>
                       <p>An SSI prevention measure can be defined as an
                         action or set of actions intentionally taken to reduce the
                         risk of an SSI. Many such techniques are directed at reducing
                         opportunities for microbial contamination of the
                         patient’s tissues or sterile surgical instruments; others are
                         adjunctive, such as using antimicrobial prophylaxis or
                         avoiding unnecessary traumatic tissue dissection.
                         Optimum application of SSI prevention measures requires
                         that a variety of patient and operation characteristics be
                         carefully considered.</p>
                         
                         <p class="topOPage"><a href="003_SSI.html#">Top</a></p>
                         
                       <h2 id="IE1"><em>1. Patient characteristics </em></h2>
                       <p>In certain kinds of operations, patient characteristics
possibly associated with an increased risk of an SSI include
coincident remote site infections [<a href="ref-SSI.html#59">59-68</a>] or colonization,[<a href="ref-SSI.html#81">81-83</a>] diabetes,
[<a href="ref-SSI.html#84">84-87</a>] cigarette smoking,[<a href="ref-SSI.html#85">85,88-92</a>] systemic steroid
use,[<a href="ref-SSI.html#84">84,87,93</a>] obesity (&gt;20% ideal body weight),[<a href="ref-SSI.html#85">85-87,94-97</a>] extremes
of age,[<a href="ref-SSI.html#92">92,98-102</a>] poor nutritional status,[<a href="ref-SSI.html#85">85,94,98,103-105</a>] and perioperative
transfusion of certain blood products.[<a href="ref-SSI.html#106">106-109</a>]</p>

                       <p class="topOPage"><a href="003_SSI.html#">Top</a></p>

                       <h3 id="IE1a">a. Diabetes                       </h3>
                       <p>The contribution of diabetes to SSI risk is controversial,
[<a href="ref-SSI.html#84">84-86,98,110</a>] because the independent contribution of diabetes
to SSI risk has not typically been assessed after
controlling for potential confounding factors. Recent preliminary
findings from a study of patients who underwent
coronary artery bypass graft showed a significant relationship
between increasing levels of HgA1c and SSI rates.[<a href="ref-SSI.html#111">111</a>]
Also, increased glucose levels (&gt;200 mg/dL) in the immediate
postoperative period (&lt;48 hours) were associated
with increased SSI risk.[<a href="ref-SSI.html#112">112,113</a>] More studies are needed to
assess the efficacy of perioperative blood glucose control
as a prevention measure.</p>

                       <p class="topOPage"><a href="003_SSI.html#">Top</a></p>

                       <h3 id="IE1b">b. Nicotine use                       </h3>
                       <p>Nicotine use delays primary wound healing and may
increase the risk of SSI.[<a href="ref-SSI.html#85">85</a>] In a large prospective study, current
cigarette smoking was an independent risk factor for
sternal and/or mediastinal SSI following cardiac surgery.[<a href="ref-SSI.html#85">85</a>]
Other studies have corroborated cigarette smoking as an
important SSI risk factor.[<a href="ref-SSI.html#88">88-92</a>] The limitation of these studies,
however, is that terms like <em>current cigarette smoking</em>
and <em>active smokers</em> are not always defined. To appropriately
determine the contribution of tobacco use to SSI risk, standardized
definitions of smoking history must be adopted
and used in studies designed to control for confounding
variables.</p>

                       <p class="topOPage"><a href="003_SSI.html#">Top</a></p>

                       <h3 id="IE1c">c. Steroid use                       </h3>
                       <p>Patients who are receiving steroids or other immuno-suppressive drugs preoperatively may be predisposed to
developing SSI,[<a href="ref-SSI.html#84">84,87</a>] but the data supporting this relationship
are contradictory. In a study of long-term steroid use
in patients with Crohn’s disease, SSI developed significantly
more often in patients receiving preoperative steroids
(12.5%) than in patients without steroid use (6.7%).[<a href="ref-SSI.html#93">93</a>] In contrast,
other investigations have not found a relationship
between steroid use and SSI risk.[<a href="ref-SSI.html#98">98,114,115</a>]</p>

                       <p class="topOPage"><a href="003_SSI.html#">Top</a></p>

                       <h3 id="IE1d">d. Malnutrition                       </h3>
                       <p>For some types of operations, severe protein-calorie
malnutrition is crudely associated with postoperative nosocomial
infections, impaired wound healing dynamics, or
death.[116-124] The National Academy of Sciences/National
Research Council (NAS/NRC),94 Study on the Efficacy of
Infection Control (SENIC),[125] and NNIS[126] schemes for SSI
risk stratification do not explicitly incorporate nutritional
status as a predictor variable, although it may be represented
indirectly in the latter two. In a widely quoted 1987
study of 404 high-risk general surgery operations, Christou
and coworkers derived an SSI probability index in which
final predictor variables were patient age, operation duration,
serum albumin level, delayed hypersensitivity test
score, and intrinsic wound contamination level.[117] Although
this index predicted SSI risk satisfactorily for 404 subsequent
patients and was generally received as a significant
advance in SSI risk stratification, it is not widely used in SSI
surveillance data analysis, surgical infection research, or
analytic epidemiology.</p>
                       <p>Theoretical arguments can be made for a belief that
severe preoperative malnutrition should increase the risk
of both incisional and organ/space SSI. However, an
epidemiologic association between incisional SSI and malnutrition
is difficult to demonstrate consistently for all surgical
subspecialties.[118-120,124,127-131] Multivariate logistic
regression modeling has shown that preoperative proteincalorie
malnutrition is not an independent predictor of mediastinitis after cardiac bypass operations.[85,132]</p>
                       <p>In the modern era, total parenteral nutrition (TPN)
                         and total enteral alimentation (TEA) have enthusiastic
                         acceptance by surgeons and critical care specialists.[118,133-137]
                         However, the benefits of preoperative nutritional repletion
                         of malnourished patients in reducing SSI risk are
                         unproven. In two randomized clinical trials, preoperative
                         &quot;nutritional therapy&quot; did not reduce incisional and
                         organ/space SSI risk.[138-141] In a recent study of high-risk
                         pancreatectomy patients with cancer, the provision of TPN
                         preoperatively had no beneficial effect on SSI risk.[142] A randomized
                         prospective trial involving 395 general and thoracic
                         surgery patients compared outcomes for malnourished
                         patients preoperatively receiving either a 7- to 15-day
                         TPN regimen or a regular preoperative hospital diet. All
                         patients were followed for 90 days postoperatively. There
                         was no detectable benefit of TPN administration on the incidence
                         of incisional or organ/space SSI.[143] Administering
                         TPN or TEA may be indicated in a number of circumstances,
                         but such repletion cannot be viewed narrowly as a
                         prevention measure for organ/space or incisional SSI risk.
                         When a major elective operation is necessary in a severely
                         malnourished patient, experienced surgeons often use both
                         pre- and postoperative nutritional support in consideration
                         of the major morbidity associated with numerous potential complications, only one of which is organ/space
SSI.[118,124,130,133,137,138,144-149] In addition, postoperative nutritional
support is important for certain major oncologic
operations,[135,136] after many operations on major trauma victims,
[134] or in patients suffering a variety of catastrophic surgical
complications that preclude eating or that trigger a
hypermetabolic state. Randomized clinical trials will be
necessary to determine if nutritional support alters SSI risk
in specific patient-operation combinations.</p>

                       <p class="topOPage"><a href="003_SSI.html#">Top</a></p>


                       <h3 id="IE1e">e. Prolonged preoperative hospital stay</h3>
                       <p>Prolonged preoperative hospital stay is frequently
suggested as a patient characteristic associated with
increased SSI risk. However, length of preoperative stay is
likely a surrogate for severity of illness and co-morbid conditions
requiring inpatient work-up and/or therapy before
the operation.[16,26,65,85,94,100,150,151]</p>

                       <p class="topOPage"><a href="003_SSI.html#">Top</a></p>

                       <h3 id="IE1f">f. Preoperative nares colonization with <em>Staphylococcus aureus                       </em></h3>
                       <p><em>S. aureus</em> is a frequent SSI isolate. This pathogen is
carried in the nares of 20% to 30% of healthy humans.[81] It
has been known for years that the development of SSI
involving <em>S. aureus</em> is definitely associated with preoperative
nares carriage of the organism in surgical patients.[81] A
recent multivariate analysis demonstrated that such carriage
was the most powerful independent risk factor for SSI
following cardiothoracic operations.[82]</p>
                       <p>Mupirocin ointment is effective as a topical agent for
                         eradicating <em>S. aureus</em> from the nares of colonized patients
                         or healthcare workers. A recent report by Kluytmans and
                         coworkers suggested that SSI risk was reduced in patients
                         who had cardiothoracic operations when mupirocin was
                         applied preoperatively to their nares, regardless of carrier
                         status.[152] In this study, SSI rates for 752 mupirocin-treated
                         patients were compared with those previously observed for
                         an untreated group of 928 historical control patients, and
                         the significant SSI rate reduction was attributed to the
                         mupirocin treatment. Concerns have been raised regarding
                         the comparability of the two patient groups.[153]
                         Additionally, there is concern that mupirocin resistance
                         may emerge, although this seems unlikely when treatment
                         courses are brief.[81] A prospective, randomized clinical trial
                         will be necessary to establish definitively that eradication of
                         nasal carriage of <em>S. aureus</em> is an effective SSI prevention
                         method in cardiac surgery. Such a trial has recently been
                         completed on 3,909 patients in Iowa.[83] Five types of operations
                         in two facilities were observed. Preliminary analysis
                         showed a significant association between nasal carriage of
                         <em>S. aureus</em> and subsequent SSI development. The effect of
                         mupirocin on reducing SSI risk is yet to be determined.</p>
                       <p class="topOPage"><a href="003_SSI.html#">Top</a></p>
                     
                       <h3 id="IE1g">g. Perioperative transfusion </h3>
                       <p>It has been reported that perioperative transfusion of
leukocyte-containing allogeneic blood components is an
apparent risk factor for the development of postoperative
bacterial infections, including SSI.[106] In three of five randomized
trials conducted in patients undergoing elective
colon resection for cancer, the risk of SSI was at least doubled
in patients receiving blood transfusions.[107-109]
However, on the basis of detailed epidemiologic reconsiderations, as many as 12 confounding variables may have
influenced the reported association, and any effect of transfusion
on SSI risk may be either small or nonexistent.106
Because of methodologic problems, including the timing of
transfusion, and use of nonstandardized SSI definitions,
interpretation of the available data is limited. A metaanalysis
of published trials will probably be required for
resolution of the controversy.[154] There is currently no scientific
basis for withholding necessary blood products
from surgical patients as a means of either incisional or
organ/space SSI risk reduction.</p>

                       <p class="topOPage"><a href="003_SSI.html#">Top</a></p>
					  <!-- InstanceEndEditable -->
					<!-- /end .main-inner --></div>
					
				  <div id="linkPolicy">&nbsp;</div>
				<!-- /end #content-main--></div>
				
			<!-- /end #content-inner --></div>
			
			<!-- ########## RIGHT COLUMN STARTS HERE ########## -->
			<div id="content-secondary">
				<div class="pageOptions">
					<div class="pageOptions-inner">
						<!-- If you're seeing this, the text-sizer include is depricated and the server-side-include reference should be removed from all pages -->
						<ul id="services" class="services">
							<li class="print"><a href="javascript:window.print();" title="Print page.">Print page</a></li>
						</ul>
						<!-- InstanceBeginEditable name="local-options" -->
					
					<!-- InstanceEndEditable -->
						<!-- InstanceBeginEditable name="languages" -->
					 
				<!-- InstanceEndEditable -->
					</div>
				</div>
				
				
				<!-- InstanceBeginEditable name="gov-delivery" -->
			
			<!-- InstanceEndEditable -->
				<!-- InstanceBeginEditable name="contact-info" -->
			<div id="contact-info">
	<h5>Contact Us:</h5>
	<ul class="noBullet">
		<li class="mail">Centers for Disease Control and Prevention<br />
		1600 Clifton Rd<br />
		Atlanta, GA 30333</li>
		<li class="phone">800-CDC-INFO<br />
		(800-232-4636)<br />
		TTY: (888) 232-6348</li>
		<li><a href="../../cdc-info/requestform.html">Contact CDC&ndash;INFO</a></li>
	</ul>
</div>
			<!-- InstanceEndEditable -->
				
			<!-- /end #content-secondary --></div>
			
		<!-- /end #content --></div>
		
		<div class="preFoot">
			<div id="plugin-legend">
			<h3>File Formats Help:</h3>
			<ul>
				<li class="plugin-pdf"><a href="../../Other/plugins/index.html#pdf"><img src="../../TemplatePackage/images/icon_pdf.gif" alt="Adobe PDF file" /></a></li>
				<li class="plugin-word"><a href="../../Other/plugins/index.html#doc"><img src="../../TemplatePackage/images/icon_word.gif" alt="Microsoft Word file" /></a></li>
				<li class="plugin-excel"><a href="../../Other/plugins/index.html#xls"><img src="../../TemplatePackage/images/icon_excel.gif" alt="Microsoft Excel file" /></a></li>
				<li class="plugin-ppt"><a href="../../Other/plugins/index.html#ppt"><img src="../../TemplatePackage/images/icon_ppt.gif" alt="Microsoft PowerPoint file" /></a></li>
				<li class="plugin-wmv"><a href="../../Other/plugins/index.html#wmv"><img src="../../TemplatePackage/images/icon_wmv.gif" alt="Audio/Video file" /></a></li>
				<li class="plugin-zip"><a href="../../Other/plugins/index.html#zip"><img src="../../TemplatePackage/images/icon_zip.gif" alt="Zip Archive file" /></a></li>
				<li class="plugin-real"><a href="../../Other/plugins/index.html#ram"><img src="../../TemplatePackage/images/icon_real.gif" alt="RealPlayer file" /></a></li>
				<li class="plugin-qt"><a href="../../Other/plugins/index.html#qt"><img src="../../TemplatePackage/images/icon_qt.gif" alt="Apple Quicktime file" /></a></li>
			</ul>
			<p><a href="../../Other/plugins/index.html"><span class="tp-label">How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?</span>&nbsp;<img src="../../TemplatePackage/images/btn_dblArrows.gif" alt="double arrows." /></a></p>
		</div>
			<div class="pageOptions-horizontal">
				<ul class="services">
					<li class="print"><a href="javascript:window.print();">Print</a></li>

					<!-- InstanceBeginEditable name="local-options-horizontal" -->
				
				<!-- InstanceEndEditable -->
				</ul>
			</div>
			<div id="datestamp"><!-- InstanceBeginEditable name="date-stamp" -->
			<ul>
				<li class="last-reviewed">Page last reviewed: <span>May 2, 2011</span></li>
				<li class="last-updated">Page last updated: <span>May 2, 2011</span></li>
				 <li class="content-source">Content source: <a href="../../index.html">Centers for Disease Control and Prevention</a><br /> <a href="../../ncezid.1.html">National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)</a><br /> <a href="../../ncezid/dhqp/index.html">Division of Healthcare Quality Promotion (DHQP)</a></li>

			</ul>
		<!-- InstanceEndEditable -->			</div>
	  </div>
		
		<div id="siteinfo">
	<div id="siteinfo-nav">
		<ul class="menu">
			<li><a href="../../index.html">Home</a></li>
			<li><a href="../../az/a.html">A-Z Index</a></li>
			<li><a href="../../Other/policies.html">Policies</a></li>
			<li><a href="../../Other/about_cdcgov.html">Using this Site</a></li>
			<li><a href="../../Other/link.html">Link to Us</a></li>
			<li class="last-child"><a href="../../contact.1.html">Contact CDC</a></li>
		</ul>
	</div>
	<div id="siteinfo-credits">
		<div id="siteinfo-logos"><a href="https://www.usa.gov//"><img id="logo_usagov" src="../../TemplatePackage/images/logo_usagov.gif" alt="USA.gov: The U.S. Government's Official Web Portal" width="188" height="55" border="0" /></a><a href="https://www.hhs.gov/"><img id="logo_dhhs" src="../../TemplatePackage/images/logo_dhhs.gif" alt="Department of Health and Human Services" width="61" height="55" border="0" /></a></div>
		<address>Centers for Disease Control and Prevention &nbsp; 1600 Clifton Road Atlanta, GA 30329-4027, USA<br />
		800-CDC-INFO (800-232-4636)	TTY: (888) 232-6348 - <a href="https://wwwn.cdc.gov/dcs/RequestForm.aspx">Contact CDC&ndash;INFO</a></address>
	</div>
</div>

<!--include virtual="/TemplatePackage/3.0/includes/interstitialModal.html" -->
		
		<div id="AZlist-container"><a name="az"></a>
	<span>A-Z Index</span>
	<ol class="AZlist">
		<li><a href="../../az/a.html">A</a></li>
		<li><a href="../../az/b.html">B</a></li>
		<li><a href="../../az/c.html">C</a></li>
		<li><a href="../../az/d.html">D</a></li>
		<li><a href="../../az/e.html">E</a></li>
		<li><a href="../../az/f.html">F</a></li>
		<li><a href="../../az/g.html">G</a></li>
		<li><a href="../../az/h.html">H</a></li>
		<li><a href="../../az/i.html">I</a></li>
		<li><a href="../../az/j.html">J</a></li>
		<li><a href="../../az/k.html">K</a></li>
		<li><a href="../../az/l.html">L</a></li>
		<li><a href="../../az/m.html">M</a></li>
		<li><a href="../../az/n.html">N</a></li>
		<li><a href="../../az/o.html">O</a></li>
		<li><a href="../../az/p.html">P</a></li>
		<li><a href="../../az/q.html">Q</a></li>
		<li><a href="../../az/r.html">R</a></li>
		<li><a href="../../az/s.html">S</a></li>
		<li><a href="../../az/t.html">T</a></li>
		<li><a href="../../az/u.html">U</a></li>
		<li><a href="../../az/v.html">V</a></li>
		<li><a href="../../az/w.html">W</a></li>
		<li><a href="../../az/x.html">X</a></li>
		<li><a href="../../az/y.html">Y</a></li>
		<li><a href="../../az/z.html">Z</a></li>
		<li><a href="../../az/0.html">#</a></li>
	</ol>
</div>

	<!-- /end #wrapper-inner --></div>
	
<!-- /end #wrapper --></div>

<!-- xxxxxxxxxxxxxxxxxx METRICS code begins here xxxxxxxxxxxxxxxxxxxxxxxxxxx-->
<div id="metrics">

<!-- Begin Google DAP inclusion -->
<script type="text/javascript" id="_fed_an_ua_tag" src="../../JScript/metrics/google/Universal-Federated-Analytics-Min.js@agency=HHS&amp;subagency=CDC"></script>
<!-- End Google DAP inclusion -->

<!-- SiteCatalyst code version: H.21. -->
<script language="JavaScript" type="text/javascript" src="../../JScript/metrics/topic_levels.js"></script>
<script language="JavaScript" type="text/javascript" src="../../JScript/metrics/s_code_v21_cdcgov.js"></script>
<script language="JavaScript" type="text/javascript">

<!-- InstanceBeginEditable name="metrics" -->
s.pageName=document.title;
s.channel="HICPAC";

siteCatalyst.setLevel1("NCEZID"); 
siteCatalyst.setLevel2("DHQP"); 
siteCatalyst.setLevel3("Healthcare Infection Control Practices Advisory Committee"); 
siteCatalyst.setLevel4("Guidelines-HICPAC"); 
<!-- InstanceEndEditable -->
s.prop2=window.location.href;
s.prop26=document.title;
s.prop30=document.title;
s.prop31=window.location.href;
s.prop46=window.location.href;
s.server=window.location.hostname;

// Update the level variables here.
updateVariables(s);

/************* DO NOT ALTER ANYTHING BELOW THIS LINE ! **************/
var s_code=s.t();if(s_code)document.write(s_code);//--></script>
<script language="JavaScript" type="text/javascript"><!--
if(navigator.appVersion.indexOf('MSIE')>=0)document.write(unescape('%3C')+'\!-'+'-');
//--></script><noscript><a href="http://www.omniture.com" title="Web Analytics"><img src="https://smtrics.cdc.gov/b/ss/cdcgov/1/H.21--NS/01/H.21--NS/0" height="1" width="1" border="0" alt="Web Analytics" /></a></noscript><!--/DO NOT REMOVE/-->
<!-- End SiteCatalyst code version: H.21. -->
<!-- Begin Template Package Custom Interactions -->
<script type="text/javascript" src="../../JScript/metrics/rd_custom_interactions.js"></script>
<!-- End Template Package Custom Interactions -->
<!-- Begin Template Package DigitalGov Search Support -->
<script type="text/javascript" src="../../JScript/rd_search.js"></script>
<!-- End Template Package DigitalGov Search Support -->
</div>
<!-- xxxxxxxxxxxxxxxxxx METRICS code ends here xxxxxxxxxxxxxxxxxxxxxxxxxxx-->



</body>
<!-- InstanceEnd --></html>
